Rebecca Lin

Direktor/Vorstandsmitglied bei

Shanghai Rarestone Health Tech Group Co. Ltd.

Consumer Services

Finance

Health Technology

Profil

Rebecca Lin is currently a Director at Shanghai Rarestone Health Tech Group Co., Ltd. and a Senior Partner & Co Head at Eight Roads Capital Advisors (CHINA) since 2021.
Education includes an undergraduate degree from Shenzhen University conferred in 1994 and an MBA from The Wharton School of the University of Pennsylvania conferred in 2000.

Aktive Positionen von Rebecca Lin

Unternehmen	Position	Beginn
Eight Roads Capital Advisors (CHINA) Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	01.06.2007
Shanghai Rarestone Health Tech Group Co. Ltd. Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Rebecca Lin

Ausbildung von Rebecca Lin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Rebecca Lin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Shenzhen University Shenzhen University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Eight Roads Capital Advisors (CHINA) Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager	Finance
Shanghai Rarestone Health Tech Group Co. Ltd. Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services	Health Technology